Tonic.ai provides tools that generate production-like synthetic datasets for developers, using differential privacy and distributed computing to de-identify sensitive data while preserving its value. The platform synthesizes fake data that mirrors complex, cross-repository relationships so developers can build and test software without exposing real customer data. Tonic emphasizes integration with CI/CD pipelines and enterprise data infrastructure, positioning the product primarily for developer workflows though it may also be useful for data scientists. CEO and co-founder Ian Coe says the system preserves consistency across applications (for example, changing a name consistently across systems) to avoid leakage of real data. The company launched in 2019 and has around 40 employees, and with the new funding it plans to hire aggressively with a goal of reaching at least 100 employees in 2022. Tonic acknowledges contemporaries like Gretel and Synthetaic but argues it is differentiated by addressing enterprise-scale data complexity and infrastructure integration. Tonic offers an all-in-one synthetic data platform that provides privacy guarantees through de-identification, subsetting, and data synthesis to equip developers with safe, production-like datasets. Its tools scale big data down to manageable, useful datasets, shorten development cycles by as much as 60%, eliminate data-pipeline overhead, and claim mathematically guaranteed privacy. Tonic reported rapid growth in 2020, tripling its team, increasing revenue by over 600%, and serving about 30 customers across industries including healthcare, financial services, logistics, edtech, and e-commerce. Customers named in the article include eBay, Flexport, and PwC. The company was founded in 2018 and maintains offices in San Francisco and Atlanta; its founders and leaders include Ian Coe (CEO), Karl Hanson (COO), Andrew Colombi (CTO), and Adam Kamor (Head of Engineering). Tonic plans to use new funding to expand its team and pursue opportunities to provide de-identified patient data to researchers in the fight against COVID-19.

Total raised

$43M

Funding rounds

2

Latest round

Series B

Latest activity

Sep 2021